Fathallah-Shaykh Sahar A
Department of Pediatrics, Division of Nephrology, University of Alabama at Birmingham, 516 Lowder Building, 1600 7th Avenue South, Birmingham, AL, 35233, USA.
Pediatr Nephrol. 2017 May;32(5):743-751. doi: 10.1007/s00467-016-3448-8. Epub 2016 Jun 27.
Proteinuria in children with chronic kidney disease (CKD) is common and its etiology differs from that in adults. How proteinuria influences the rate of progression of CKD has been analyzed in multiple retrospective clinical studies and more recently in a few prospective ones. In this review I summarize the results, strengths and weaknesses of each of these studies. The findings of several retrospective studies in children with CKD have confirmed what we have learned from adult studies on the association between proteinuria and worsening kidney function. Larger prospective clinical studies have examined the effects of proteinuria on the rate of decline of kidney function and the risk of end-stage kidney disease. They have also considered children with glomerular and, more importantly, the more common, congenital causes of CKD. Current studies have important strengths but also a few weaknesses that limit the validity of the conclusions which can be drawn. There is still a need for large clinical trials that focus primarily on studying the influence of proteinuria on kidney function and on finding remedies that delay progression.
慢性肾脏病(CKD)患儿蛋白尿很常见,其病因与成人不同。多项回顾性临床研究以及最近的一些前瞻性研究分析了蛋白尿如何影响CKD的进展速度。在这篇综述中,我总结了这些研究各自的结果、优点和不足。几项针对CKD患儿的回顾性研究结果证实了我们从成人研究中所了解到的蛋白尿与肾功能恶化之间的关联。更大规模的前瞻性临床研究考察了蛋白尿对肾功能下降速度和终末期肾病风险的影响。这些研究还纳入了患有肾小球疾病的儿童,更重要的是,纳入了患有更为常见的先天性CKD病因的儿童。当前的研究有重要优点,但也存在一些不足,限制了所能得出结论的有效性。仍然需要开展主要聚焦于研究蛋白尿对肾功能的影响以及寻找延缓疾病进展疗法的大型临床试验。